Delivery Order SPE2DB22D2214-SPE2DB24FS3YX
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,937,659 units of the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a ceiling value of $1,436.41 and a completion date of March 13, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The $2,803.07 contract has a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,472.66 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4565470089 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,252.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML medication. The $1,060.98 contract has a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,742.90 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, with a completion date of April 26, 2024. This award is part of Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, under which the company provides a wide range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML medication. The $1,175.27 firm fixed price contract has an ultimate completion date of October 30, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a $1,079.69 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of the drug XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, with a period of performance ending on June 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product, with a ceiling value of $2,353.76 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the provision of a specialty pharmaceutical product, XYOSTED 75 mg/0.5 ml auto-injector, which is used in military treatment programs and facilities. The contract has a ceiling value of $1,068.51 and a performance period ending on...